Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Agios Pharm
8APCurrent price
51.5 EUR
-3.49 EUR (-6.36%)
Last closed
55.4 USD
Company
www.agios.com
ISIN
US00847X1046
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
3 368 203 776 USD
Yield for 12 month
+141.60 %
1Y
3Y
5Y
10Y
15Y
8AP
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Address: 88 Sidney Street, Cambridge, MA, United States, 02139
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
55 USDP/E ratio
5.0652Dividend Yield
–Current Year
+26 823 000 USD
Last Year
+14 240 000 USD
Current Quarter
+8 964 000 USD
Last Quarter
+8 615 000 USD
Current Year
+17 319 000 USD
Last Year
+12 536 000 USD
Current Quarter
+8 181 000 USD
Last Quarter
+5 527 000 USD
Key Figures 8AP
1 year
3 years
5 years
10 years
EBITDA
-401 288 000 USD
Operating Margin TTM
PE Ratio
5.0652
Return On Assets TTM
-18.18 %
PEG Ratio
–
Return On Equity TTM
53.66 %
Wall Street Target Price
55 USD
Revenue TTM
32 871 000 USD
Book Value
28.53 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
21.2 %
Dividend Yield
–
Gross Profit TTM
12 536 000 USD
Earnings per share
11.66 USD
Diluted Eps TTM
11.66 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
2051.38 %
Dividend Analytics 8AP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 8AP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 8AP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
5.0652
Forward PE
2.4655
Enterprise Value Revenue
73.7513
Price Sales TTM
102.4673
Enterprise Value EBITDA
-2.3282
Price Book MRQ
2.0706
Financials 8AP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 8AP
For 52 weeks
20.96 USD
62.58 USD
50 Day MA
45.15 USD
Shares Short Prior Month
3 275 023
200 Day MA
38.64 USD
Short Ratio
6.65
Shares Short
4 108 097
Short Percent
7.31 %
BeatStart